RXRG and non-small cell lung carcinoma: A correlation between RXRγ upregulation and Gefitinib treatment has been previously indicated by the cooperative antitumor activity of the RXRγ-selective agonist Bexarotene and Gefitinib in preclinical models of non-small cell lung cancer [61].